Cargando…

Targeted Delivery of Chemotherapeutic Agents for Osteosarcoma Treatment

Since osteosarcoma (OS) is an aggressive bone cancer with unknown molecular pathways of etiology and pathophysiology, improving patient survival has long been a challenge. The conventional therapy is a complex multidisciplinary management that include radiotherapy, chemotherapy which followed by sur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Duoli, Wang, Zhuqian, Li, Jie, Guo, De-an, Lu, Aiping, Liang, Chao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931218/ https://www.ncbi.nlm.nih.gov/pubmed/35311145 http://dx.doi.org/10.3389/fonc.2022.843345

Ejemplares similares

Toward Overcoming Treatment Failure in Rheumatoid Arthritis
por: Wang, Zhuqian, et al.
Publicado: (2021)

Curcumin in Osteosarcoma Therapy: Combining With Immunotherapy, Chemotherapeutics, Bone Tissue Engineering Materials and Potential Synergism With Photodynamic Therapy
por: Xu, Chunfeng, et al.
Publicado: (2021)

Chemotherapeutic Effectiveness of Combining Cetuximab for Metastatic Colorectal Cancer Treatment: A System Review and Meta-Analysis
por: Li, Rong, et al.
Publicado: (2020)

Integrin Targeted Delivery of Chemotherapeutics
por: Chen, Kai, et al.
Publicado: (2011)

Prognostic influence of PD-1/PD-L1 suppressors in combination with chemotherapeutic agents for non-small cell pulmonary carcinoma: system review and meta-analysis
por: Shen, Min, et al.
Publicado: (2023)

5-Fluorouracil: A Narrative Review on the Role of Regulatory Mechanisms in Driving Resistance to This Chemotherapeutic Agent
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2021)

Phospholipid prodrug conjugates of insoluble chemotherapeutic agents for ultrasound targeted drug delivery
por: Márquez, Mendi G., et al.
Publicado: (2020)

Nanocarrier-mediated co-delivery of chemotherapeutic drugs and gene agents for cancer treatment
por: Kang, Lin, et al.
Publicado: (2015)

Receptor Tyrosine Kinases in Osteosarcoma Treatment: Which Is the Key Target?
por: Tian, Zhichao, et al.
Publicado: (2020)

Multifunctional Nanosystem for Targeted and Controlled Delivery of Multiple Chemotherapeutic Agents for the Treatment of Drug-Resistant Breast Cancer
por: Lou, Song, et al.
Publicado: (2018)

The Clinical Implications of Tumor Mutational Burden in Osteosarcoma
por: Xie, Lu, et al.
Publicado: (2021)

Acquisition of anoikis resistance in human osteosarcoma cells does not alter sensitivity to chemotherapeutic agents
por: Díaz-Montero, C Marcela, et al.
Publicado: (2005)

A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment
por: Wang, Da, et al.
Publicado: (2019)

Construction of targeted (10)B delivery agents and their uptake in gastric and pancreatic cancer cells
por: Wang, Song, et al.
Publicado: (2023)

Tumor Delivery of Chemotherapy Combined with Inhibitors of Angiogenesis and Vascular Targeting Agents
por: Cesca, Marta, et al.
Publicado: (2013)

Covalent Organic Frameworks as Nanocarriers for Improved Delivery of Chemotherapeutic Agents
por: Liu, Weiming, et al.
Publicado: (2022)

Nail Changes With Chemotherapeutic Agents and Targeted Therapies
por: Mittal, Shankila, et al.
Publicado: (2022)

Clinicopathological Prognostic Factors and Chemotherapeutic Outcome for Two Histopathological Types of Ampulla of Vater Adenocarcinoma
por: Xia, Tao, et al.
Publicado: (2021)

Recent Advances in Nanoplatforms for the Treatment of Osteosarcoma
por: Wu, Kunzhe, et al.
Publicado: (2022)

Identification of Potential Therapeutic Targets and Immune Cell Infiltration Characteristics in Osteosarcoma Using Bioinformatics Strategy
por: Niu, Jianfang, et al.
Publicado: (2020)

Prediction and Identification of GPCRs Targeting for Drug Repurposing in Osteosarcoma
por: Tan, Manli, et al.
Publicado: (2022)

Inhibition of the mRNA-Binding Protein IGF2BP1 Suppresses Proliferation and Sensitizes Neuroblastoma Cells to Chemotherapeutic Agents
por: Biegel, Jason M., et al.
Publicado: (2021)

Chemotherapeutic Compounds Targeting the DNA Double-Strand Break Repair Pathways: The Good, the Bad, and the Promising
por: Jekimovs, Christian, et al.
Publicado: (2014)

MTHFR Polymorphism Is Associated With Severe Methotrexate-Induced Toxicity in Osteosarcoma Treatment
por: Zhang, Wenchao, et al.
Publicado: (2021)

Targeted concurrent and sequential delivery of chemotherapeutic and antiangiogenic agents to the brain by using drug-loaded nanofibrous membranes
por: Tseng, Yuan-Yun, et al.
Publicado: (2017)

Evaluation of Chemotherapeutic Agents
por: Engstrom, W. W.
Publicado: (1949)

EMT and Cancer Cell Stemness Associated With Chemotherapeutic Resistance in Esophageal Cancer
por: Liu, Xiaojie, et al.
Publicado: (2021)

Molecular mechanisms of osteosarcoma metastasis and possible treatment opportunities
por: Du, Xinhui, et al.
Publicado: (2023)

Novel Immunotherapies for Osteosarcoma
por: Lu, Yubao, et al.
Publicado: (2022)

Incidence of Cancer Treatment–Induced Arrhythmia Associated With Novel Targeted Chemotherapeutic Agents
por: Nickel, Andrew C., et al.
Publicado: (2018)

Genetically Engineered Vaccinia Viruses As Agents for Cancer Treatment, Imaging, and Transgene Delivery
por: Haddad, Dana
Publicado: (2017)

Case Report: Primary osteosarcoma of the kidney
por: Chen, Junyong, et al.
Publicado: (2023)

Optimization of Drug Delivery Systems for Intraperitoneal Therapy to Extend the Residence Time of the Chemotherapeutic Agent
por: De Smet, L., et al.
Publicado: (2013)

A systematic review on intra-arterial cerebral infusions of chemotherapeutics in the treatment of glioblastoma multiforme: The state-of-the-art
por: Pinkiewicz, Mateusz, et al.
Publicado: (2022)

Analysis of the Efficacy of Multidrug Combination Chemotherapy Regimens for Osteosarcoma and the Management of Chemotherapeutic Reactions
por: Tian, Dawei, et al.
Publicado: (2022)

A Primary Extraskeletal Osteosarcoma of the Spleen: Rare Case Report
por: Pan, Xian, et al.
Publicado: (2022)

Single-Cell Transcriptomics Reveals the Complexity of the Tumor Microenvironment of Treatment-Naive Osteosarcoma
por: Liu, Yun, et al.
Publicado: (2021)

Osteosarcoma subtypes based on platelet-related genes and tumor microenvironment characteristics
por: Shu, Yuan, et al.
Publicado: (2022)

A Review of Thermo- and Ultrasound-Responsive Polymeric Systems for Delivery of Chemotherapeutic Agents
por: Zardad, Az-Zamakhshariy, et al.
Publicado: (2016)

Macrophages in Osteosarcoma Immune Microenvironment: Implications for Immunotherapy
por: Luo, Zhong-Wei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j1pqfm8o1ibrpripjg6runpbpo